181 related articles for article (PubMed ID: 22683726)
1. Lipopolysaccharide upregulates α7 acetylcholine receptors: stimulation with GTS-21 mitigates growth arrest of macrophages and improves survival in burned mice.
Khan MA; Farkhondeh M; Crombie J; Jacobson L; Kaneki M; Martyn JA
Shock; 2012 Aug; 38(2):213-9. PubMed ID: 22683726
[TBL] [Abstract][Full Text] [Related]
2. Prevention of Burn-Induced Inflammatory Responses and Muscle Wasting by GTS-21, a Specific Agonist for α7 Nicotinic Acetylcholine Receptors.
Kashiwagi S; Khan MA; Yasuhara S; Goto T; Kem WR; Tompkins RG; Kaneki M; Martyn JA
Shock; 2017 Jan; 47(1):61-69. PubMed ID: 27529131
[TBL] [Abstract][Full Text] [Related]
3. An ALPHA7 Nicotinic Acetylcholine Receptor Agonist (GTS-21) Promotes C2C12 Myonuclear Accretion in Association with Release of Interleukin-6 (IL-6) and Improves Survival in Burned Mice.
Khan MAS; Khan MF; Kashiwagi S; Kem WR; Yasuhara S; Kaneki M; Tompkins RG; Martyn JAJ
Shock; 2017 Aug; 48(2):227-235. PubMed ID: 28282360
[TBL] [Abstract][Full Text] [Related]
4. α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-α production and lung injury.
Kox M; Pompe JC; Peters E; Vaneker M; van der Laak JW; van der Hoeven JG; Scheffer GJ; Hoedemaekers CW; Pickkers P
Br J Anaesth; 2011 Oct; 107(4):559-66. PubMed ID: 21771746
[TBL] [Abstract][Full Text] [Related]
5. GTS-21 attenuates lipopolysaccharide-induced inflammatory cytokine production in vitro by modulating the Akt and NF-κB signaling pathway through the α7 nicotinic acetylcholine receptor.
Yue Y; Liu R; Cheng W; Hu Y; Li J; Pan X; Peng J; Zhang P
Int Immunopharmacol; 2015 Dec; 29(2):504-512. PubMed ID: 26490221
[TBL] [Abstract][Full Text] [Related]
6. GTS-21 has cell-specific anti-inflammatory effects independent of α7 nicotinic acetylcholine receptors.
Garg BK; Loring RH
PLoS One; 2019; 14(4):e0214942. PubMed ID: 30947238
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of alpha 7 cholinergic receptors inhibits lipopolysaccharide-induced neutrophil recruitment by a tumor necrosis factor alpha-independent mechanism.
Giebelen IA; van Westerloo DJ; LaRosa GJ; de Vos AF; van der Poll T
Shock; 2007 Apr; 27(4):443-7. PubMed ID: 17414429
[TBL] [Abstract][Full Text] [Related]
8. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung.
Giebelen IA; van Westerloo DJ; LaRosa GJ; de Vos AF; van der Poll T
Shock; 2007 Dec; 28(6):700-3. PubMed ID: 17621262
[TBL] [Abstract][Full Text] [Related]
9. Nonopioid GTS-21 Mitigates Burn Injury Pain in Rats by Decreasing Spinal Cord Inflammatory Responses.
Zhou Y; Leung-Pitt Y; Deng H; Ren Y; You Z; Kem WR; Shen S; Zhang W; Mao J; Martyn JAJ
Anesth Analg; 2021 Jan; 132(1):240-252. PubMed ID: 33264122
[TBL] [Abstract][Full Text] [Related]
10. α7 nAChRs expressed on antigen presenting cells are insensitive to the conventional antagonists α-bungarotoxin and methyllycaconitine.
Mashimo M; Takeshima S; Okuyama H; Matsurida A; Murase M; Ono S; Kawashima K; Fujii T
Int Immunopharmacol; 2020 Apr; 81():106276. PubMed ID: 32044666
[TBL] [Abstract][Full Text] [Related]
11. GTS-21 Protected Against LPS-Induced Sepsis Myocardial Injury in Mice Through α7nAChR.
Kong W; Kang K; Gao Y; Liu H; Meng X; Cao Y; Yang S; Liu W; Zhang J; Yu K; Zhao M
Inflammation; 2018 Jun; 41(3):1073-1083. PubMed ID: 29680908
[TBL] [Abstract][Full Text] [Related]
12. The α7 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide-induced TNF-α release from microglia.
Thomsen MS; Mikkelsen JD
J Neuroimmunol; 2012 Oct; 251(1-2):65-72. PubMed ID: 22884467
[TBL] [Abstract][Full Text] [Related]
13. Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis.
Pavlov VA; Ochani M; Yang LH; Gallowitsch-Puerta M; Ochani K; Lin X; Levi J; Parrish WR; Rosas-Ballina M; Czura CJ; Larosa GJ; Miller EJ; Tracey KJ; Al-Abed Y
Crit Care Med; 2007 Apr; 35(4):1139-44. PubMed ID: 17334244
[TBL] [Abstract][Full Text] [Related]
14. The α7 nicotinic acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function.
Sitapara RA; Antoine DJ; Sharma L; Patel VS; Ashby CR; Gorasiya S; Yang H; Zur M; Mantell LL
Mol Med; 2014 Jun; 20(1):238-47. PubMed ID: 24664237
[TBL] [Abstract][Full Text] [Related]
15. Monocytes primed with GTS-21/α7 nAChR (nicotinic acetylcholine receptor) agonist develop anti-inflammatory memory.
Yang X; Zhao C; Chen X; Jiang L; Su X
QJM; 2017 Jul; 110(7):437-445. PubMed ID: 28082382
[TBL] [Abstract][Full Text] [Related]
16. Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson's Disease Mouse Models.
Park JE; Leem YH; Park JS; Kim DY; Kang JL; Kim HS
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457238
[TBL] [Abstract][Full Text] [Related]
17. Effects of the α7 nicotinic acetylcholine receptor agonist GTS-21 on the innate immune response in humans.
Kox M; Pompe JC; Gordinou de Gouberville MC; van der Hoeven JG; Hoedemaekers CW; Pickkers P
Shock; 2011 Jul; 36(1):5-11. PubMed ID: 21368716
[TBL] [Abstract][Full Text] [Related]
18. GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation.
Kox M; van Velzen JF; Pompe JC; Hoedemaekers CW; van der Hoeven JG; Pickkers P
Biochem Pharmacol; 2009 Oct; 78(7):863-72. PubMed ID: 19576181
[TBL] [Abstract][Full Text] [Related]
19. GTS-21, a mixed nicotinic receptor agonist/antagonist, does not affect the nicotine cue.
van Haaren F; Anderson KG; Haworth SC; Kem WR
Pharmacol Biochem Behav; 1999 Oct; 64(2):439-44. PubMed ID: 10515327
[TBL] [Abstract][Full Text] [Related]
20. The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE.
Rosas-Ballina M; Goldstein RS; Gallowitsch-Puerta M; Yang L; Valdés-Ferrer SI; Patel NB; Chavan S; Al-Abed Y; Yang H; Tracey KJ
Mol Med; 2009; 15(7-8):195-202. PubMed ID: 19593403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
